Meribank Biotech Co

Meribank Biotech Co Enterprise Value

The Enterprise Value (EV) of Meribank Biotech Co (4724.TWO) as of Oct 20, 2026 is 1.43 B TWD. In the previous year, Enterprise Value (EV) was 2.05 B TWD — a change of -30.30% (lower).

Enterprise Value

1.43 BTWD

YoY

-30.30%

Last updated:

Enterprise Value (EV) of Meribank Biotech Co is 2025 1.43 B TWD. Enterprise Value (EV) of Meribank Biotech Co was 2024 2.05 B TWD. It decreases by -30.30% lower compared to the previous year.

The Meribank Biotech Co Enterprise Value history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Enterprise Value
Date
Enterprise Value
Jan 1, 2019
1.19 B TWD
Jan 1, 2020
1.25 B TWD
Jan 1, 2021
1.04 B TWD
Jan 1, 2022
1.11 B TWD
Jan 1, 2023
911.07 M TWD
Jan 1, 2024
2.05 B TWD
Jan 1, 2025
1.43 B TWD
The Meribank Biotech Co Enterprise Value history
YEAREnterprise ValueYoY
1.43 BTWD-30.30%
2.05 BTWD+125.48%
911.07 MTWD-18.25%
1.11 BTWD+6.83%
1.04 BTWD-16.48%
1.25 BTWD+4.92%
1.19 BTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Meribank Biotech Co Stock analysis

What does Meribank Biotech Co do? Meribank Biotech Co., Ltd. generates revenue by engaging in the research and development of stem cell technologies. The firm provides cord blood storage and application services for hematopoietic stem cells, as well as placenta and umbilical cord storage and application services for mesenchymal stem cells. Additionally, the company offers peripheral blood stem cell storage service and application service to its clients. The business model extends to the promotion of stem cell transplantation application and the development of new stem cell processing technology and storage application services. Meribank Biotech Co., Ltd. also develops allogeneic umbilical cord mesenchymal stem cell manufacturing and therapeutic applications, creating value through these specialized biotechnological offerings. Meribank Biotech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Meribank Biotech Co stock

Enterprise Value (EV) of Meribank Biotech Co is 1.43 B TWD in 2025.

Enterprise Value (EV) of Meribank Biotech Co changed from 2.05 B TWD to 1.43 B TWD, representing a -30.30% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Enterprise Value (EV) Meribank Biotech Co since 2006 – with annual values, charts, and detailed analysis.

Enterprise Value represents the total value of a company, including both equity and debt, minus cash. It provides a more comprehensive picture than market capitalization alone.

EV = Market Capitalization + Total Debt - Cash & Equivalents

To evaluate Enterprise Value (EV)'s TWD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Enterprise Value (EV).

A 'good' TWD varies by industry and company stage. On Eulerpool, you can compare Enterprise Value (EV)'s Meribank Biotech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Valuation — Meribank Biotech Co

P/EP/SEV/EBITP/BP/CFP/FCFPEGEV/RevenueEV/EBITDAEV/FCFEarnings YieldFCF YieldMarket capitalizationEnterprise ValueForward P/EP/TBVShareholder YieldBuyback YieldDiv.-Adj. PEGEV/OCF

All Key Metrics — Meribank Biotech Co